TAK 778

CAS: 180185-61-9

Ref. 3D-FHA18561

Produktinformation

• Name: TAK 778
• Synonyme: Tak-778-Sr, Tak-778, (6R,8S)-(-)-N-[4-(Diethoxyphosphorylmethyl)phenyl]-8-methyl-9-oxo-5,6,8,9-tetrahydrothiepino[4,5-f]-1,3-benzodioxole-6-carboxamide

Beschreibung

TAK 778 is an orally bioavailable small molecule that has been shown to inhibit the activity of phosphatase and act as a cavity-forming agent. TAK 778 has been shown to increase bone growth in vivo and enhance bone repair in vitro. This drug also stimulates the proliferation of human osteoblasts when used in vitro, which is likely due to its ability to inhibit the activity of phosphatase. TAK 778 is capable of inducing insulin-like growth factor-I (IGF-I) production by cultured hepatocytes, which may be due to its inhibition of phosphatase.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 505.5 g/mol
• Formel: C₂₄H₂₈NO₇PS
• Reinheit: Min. 95%